Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of Treatment.
暂无分享,去创建一个
K. Jünemann | E. Chartier-Kastler | V. Nitti | S. Herschorn | E. Rovner | G. Del Popolo | M. Joshi | A. Kohan | A. Magyar